Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain-Reference-Cited by-同舟云学术

Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain

Published:2012-05-16 Issue:5 Volume:7 Page:e35600
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fernández Oscar,Agüera Javier,Izquierdo Guillermo,Millán-Pascual Javier,Ramió i Torrentà Lluis,Oliva Pedro,Argente Javier,Berdei Yasmina,Soler Jose Maria,Carmona Olga,Errea Jose Maria,Farrés Jordi,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. The epidemiology of multiple sclerosis in Europe.;M Pugliatti;Eur J Neurol,2006

2. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability.;BG Weinshenker;Brain,1989

3. Early stage and long term treatment of multiple sclerosis with interferon-beta.;A Applebee;Biologics,2009

4. Interferon beta-1b is effective in relapsing remitting multiple sclerosis. I. Clinical results of a multicenter,randomized, double-blind, placebo-controlled trial.;Neurology,1993

5. Placebo-controlled multicenter randomized trial of interferon β-1b in treatment of secondary progressive multiple sclerosis.;Lancet,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment satisfaction with disease-modifying therapy is the only predictor of Adherence among multiple sclerosis patients from Upper Egypt;Scientific Reports;2024-03-25

2. Adherence to disease-modifying therapies among patients with multiple sclerosis in Bulgaria – A real world study;Pharmacia;2024-02-15

3. Adherence, Persistence, Switching and Costs of Injectable and Oral Therapies for Multiple Sclerosis. Real Life Analysis Over 6 Years of Treatment;Hospital Pharmacy;2024-02-15

4. Factors Associated with Therapeutic Adherence in Multiple Sclerosis in Spain;Patient Preference and Adherence;2023-03

5. THE EFFECT OF SOCIO-DEMOGRAPHIC FEATURES AND PERCEIVED SOCIAL SUPPORT ON TREATMENT COMPLIANCE IN PATIENTS WITH MULTIPLE SCLEROSIS;International Journal of Disabilities Sports & Health Sciences;2022-08-08